Back to Centiva Capital, LP Centiva Capital, LP

ADPTADPT

Showing 2 of 9 quarters

Position history for Centiva Capital, LPCentiva Capital, LP's holdings in ADAPTIVE BIOTECHNOLOGIES

No. Centiva Capital exited its ADPT (Adaptive Biotechnologies) position in Q4 2024. Its Q3 2024 13F listed 15,635 shares worth $80,051. Centiva Capital first reported ADPT in Q4 2020 and held it in 5 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$80,051

Total Shares Change

-15,635

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$6.11
0
2024-Q3
New
15,635
—
$80,0510.0%$5.00
30

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used